CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $3.03 ($60,600)
- 8-K Event Shareholder vote results
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $3.04 ($60,800)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 18,355 shares at $2.72 ($49,926)
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,215 shares at $2.47 ($49,931)
- 4 Open-market buy Director bought 192,516 shares at an average $2.18 ($420,482)
- 4 Open-market buy Director bought 192,516 shares at an average $2.18 ($420,482)
- 4 Open-market buy Director bought 125,359 shares at an average $1.57 ($197,252)
- 4 Open-market buy Director bought 125,359 shares at an average $1.57 ($197,252)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 27,836 shares at $1.80 ($50,105)
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-K Report Annual Report
Page 12 of 19 · 362 filings